Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Relation of CD117 immunoreactivity and microvascular density in invasive breast carcinoma.

Amin MM, El-Hawary AK, Farouk O.

Indian J Pathol Microbiol. 2012 Oct-Dec;55(4):456-60. doi: 10.4103/0377-4929.107780.

2.

Stromal CD10 expression in invasive breast carcinoma correlates with poor prognosis, estrogen receptor negativity, and high grade.

Makretsov NA, Hayes M, Carter BA, Dabiri S, Gilks CB, Huntsman DG.

Mod Pathol. 2007 Jan;20(1):84-9. Epub 2006 Nov 24.

3.
4.

Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer.

Shpitz B, Bomstein Y, Sternberg A, Klein E, Liverant S, Groisman G, Bernheim J.

J Surg Oncol. 2000 Dec;75(4):252-7.

PMID:
11135266
5.

CD117 immunoreactivity in stage I adenocarcinoma and squamous cell carcinoma of the lung: relevance to prognosis in a subset of adenocarcinoma patients.

Pelosi G, Barisella M, Pasini F, Leon ME, Veronesi G, Spaggiari L, Fraggetta F, Iannucci A, Masullo M, Sonzogni A, Maffini F, Viale G.

Mod Pathol. 2004 Jun;17(6):711-21.

6.

CD34, CD117, and actin expression in phyllodes tumor of the breast.

Chen CM, Chen CJ, Chang CL, Shyu JS, Hsieh HF, Harn HJ.

J Surg Res. 2000 Dec;94(2):84-91.

PMID:
11104647
7.

Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.

Khalifeh IM, Albarracin C, Diaz LK, Symmans FW, Edgerton ME, Hwang RF, Sneige N.

Am J Surg Pathol. 2008 Apr;32(4):544-52. doi: 10.1097/PAS.0b013e31815a87e2.

PMID:
18300793
8.

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.

Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A.

Hum Pathol. 2009 Nov;40(11):1528-33. doi: 10.1016/j.humpath.2009.05.005. Epub 2009 Aug 19.

PMID:
19695680
9.

The analysis of CD34 antigen immunoreactivity level in invasive ductal breast cancer with respect to the presence of lymph node metastases.

Popiela TJ, Sikora J, Klimek M, Basta P, Niemiec T, Dobrogowski J, Kotlarz A, Rudnicka-Sosin L, Dutsch-Wicherek M.

Neuro Endocrinol Lett. 2008 Aug;29(4):443-6.

PMID:
18766141
10.

CD117 and CD34 staining patterns in childhood benign mammary lesions.

Kaçar A, Paker I, Akbiyik F, Arikök AT, Mambet E.

Turk Patoloji Derg. 2012;28(1):31-7. doi: 10.5146/tjpath.2012.01094.

11.
12.
13.

Immunostaining with D2-40 improves evaluation of lymphovascular invasion, but may not predict sentinel lymph node status in early breast cancer.

Britto AV, Schenka AA, Moraes-Schenka NG, Alvarenga M, Shinzato JY, Vassallo J, Ward LS.

BMC Cancer. 2009 Apr 8;9:109. doi: 10.1186/1471-2407-9-109.

14.

[Expressions of D2-40 and CD34 in invasive ductal carcinoma of the breast and the clinical implications].

Zhen LF, Ye CS, Liu MF, Ding GP, Liao JJ.

Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jul;30(7):1548-51. Chinese.

15.

MTA1 overexpression correlates significantly with tumor grade and angiogenesis in human breast cancers.

Jang KS, Paik SS, Chung H, Oh YH, Kong G.

Cancer Sci. 2006 May;97(5):374-9.

16.

Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: relation to tumor phenotype and clinical outcome.

Mylona E, Magkou C, Giannopoulou I, Agrogiannis G, Markaki S, Keramopoulos A, Nakopoulou L.

Breast Cancer Res. 2006;8(5):R57.

17.

LEA-135 expression: its association with a lower risk of recurrence and increased overall survival of patients with lymph node-positive primary invasive breast cancer.

Saha B, Zhang N, Naritoku WY, Tsao-Wei DD, Groshen SL, Carlsson G, Larsson L, Gustavsson B, Chaiwun B, Taylor CR, Imam SA.

Anticancer Res. 2004 Jul-Aug;24(4):2391-400.

18.

CD117 expression in breast phyllodes tumors correlates with adverse pathologic parameters and reduced survival.

Tan WJ, Thike AA, Tan SY, Tse GM, Tan MH, Bay BH, Tan PH.

Mod Pathol. 2015 Mar;28(3):352-8. doi: 10.1038/modpathol.2014.111. Epub 2014 Sep 12.

19.

Comparison of Microvessel Density with Prognostic Factors in Invasive Ductal Carcinomas of the Breast.

Şener E, Şipal S, Gündoğdu C.

Turk Patoloji Derg. 2016;32(3):164-70. doi: 10.5146/tjpath.2016.01366.

20.

Macrophage infiltration and its prognostic implications in breast cancer: the relationship with VEGF expression and microvessel density.

Tsutsui S, Yasuda K, Suzuki K, Tahara K, Higashi H, Era S.

Oncol Rep. 2005 Aug;14(2):425-31.

PMID:
16012726

Supplemental Content

Support Center